These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 17535202)

  • 1. Heterozygous prothrombin gene mutation associated with livedoid vasculopathy.
    Anavekar NS; Kelly R
    Australas J Dermatol; 2007 May; 48(2):120-3. PubMed ID: 17535202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ulcerations caused by livedoid vasculopathy associated with a prothrombotic state: Response to warfarin.
    Davis MD; Wysokinski WE
    J Am Acad Dermatol; 2008 Mar; 58(3):512-5. PubMed ID: 18280355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of livedoid vasculopathy associated with factor V Leiden mutation: successful treatment with oral warfarin.
    Kavala M; Kocaturk E; Zindanci I; Turkoglu Z; Altintas S
    J Dermatolog Treat; 2008; 19(2):121-3. PubMed ID: 18484430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity (4G/4G) treated successfully with tissue plasminogen activator.
    Deng A; Gocke CD; Hess J; Heyman M; Paltiel M; Gaspari A
    Arch Dermatol; 2006 Nov; 142(11):1466-9. PubMed ID: 17116837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Warfarin therapy for livedoid vasculopathy associated with cryofibrinogenemia and hyperhomocysteinemia.
    Browning CE; Callen JP
    Arch Dermatol; 2006 Jan; 142(1):75-8. PubMed ID: 16415390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Livedoid vasculopathy and its association with factor V Leiden mutation.
    Yong AA; Tan AW; Giam YC; Tang MB
    Singapore Med J; 2012 Dec; 53(12):e258-60. PubMed ID: 23268168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leg ulcers associated with factor V Leiden and prothrombin G20210A and methyltetrahydrofolate reductase mutations: successful treatment with warfarin.
    Clivati Brandt HR; de Lorenzo Messina MC; Belda Júnior W; Costa Martins JE; Criado PR
    Int J Dermatol; 2007 Dec; 46(12):1319-20. PubMed ID: 18173539
    [No Abstract]   [Full Text] [Related]  

  • 8. Heterozygous prothrombin G20210A gene mutation in a patient with livedoid vasculitis.
    Gotlib J; Kohler S; Reicherter P; Oro AE; Zehnder JL
    Arch Dermatol; 2003 Aug; 139(8):1081-3. PubMed ID: 12925402
    [No Abstract]   [Full Text] [Related]  

  • 9. [Recurrent leg ulcers due to livedoid vasculopathy: successful treatment with low-molecular-weight heparin].
    Becker A; Stoffels-Weindorf M; Schimming T; Dissemond J
    Dtsch Med Wochenschr; 2013 Jul; 138(28-29):1458-62. PubMed ID: 23821447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe livedoid vasculopathy associated with antiphosphatidylserine-prothrombin complex antibody successfully treated with warfarin.
    Noda S; Asano Y; Yamazaki M; Ichimura Y; Tamaki Z; Takekoshi T; Sugaya M; Sato S
    Arch Dermatol; 2011 May; 147(5):621-3. PubMed ID: 21576587
    [No Abstract]   [Full Text] [Related]  

  • 11. Frequency of thrombophilia determinant factors in patients with livedoid vasculopathy and treatment with anticoagulant drugs--a prospective study.
    Di Giacomo TB; Hussein TP; Souza DG; Criado PR
    J Eur Acad Dermatol Venereol; 2010 Nov; 24(11):1340-6. PubMed ID: 20337814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Livedoid vasculopathy with heterozygous factor V Leiden mutation and sticky platelet syndrome].
    Lewerenz V; Burchardt T; Büchau A; Ruzicka T; Megahed M
    Hautarzt; 2004 Apr; 55(4):379-81. PubMed ID: 15021932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case of livedoid vasculopathy with peripheral neuropathy successfully treated with low-dose warfarin.
    Osada S; Kimura Y; Kawana S
    J Dermatol; 2010 Jan; 37(1):98-101. PubMed ID: 20175830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Livedoid vasculopathy: further evidence for procoagulant pathogenesis.
    Hairston BR; Davis MD; Pittelkow MR; Ahmed I
    Arch Dermatol; 2006 Nov; 142(11):1413-8. PubMed ID: 17116831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Livedoid vasculopathy in a patient with factor V mutation (Leiden).
    Biedermann T; Flaig MJ; Sander CA
    J Cutan Pathol; 2000 Sep; 27(8):410-2. PubMed ID: 10955688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vasculitis and vasculopathy].
    Marković A
    Acta Med Croatica; 2012 Oct; 66 Suppl 1():19-24. PubMed ID: 23193816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Livedoid vasculopathy: long-term follow-up results following hyperbaric oxygen therapy.
    Juan WH; Chan YS; Lee JC; Yang LC; Hong HS; Yang CH
    Br J Dermatol; 2006 Feb; 154(2):251-5. PubMed ID: 16433793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropathy in a patient with lymphocytic thrombophilic arteritis.
    Shen S; Williams RA; Kelly RI
    Australas J Dermatol; 2013 May; 54(2):e28-32. PubMed ID: 23582000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Livedoid vasculopathy (white atrophy) associated with anticardiolipin antibodies].
    Grasland A; Crickx B; Blanc M; Pouchot J; Vinceneux P
    Ann Med Interne (Paris); 2000 Sep; 151(5):408-10. PubMed ID: 11033476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Livedoid vasculopathy and hypercoagulability in a patient with primary Sjögren's syndrome.
    Cardoso R; Gonçalo M; Tellechea O; Maia R; Borges C; Silva JA; Figueiredo A
    Int J Dermatol; 2007 Apr; 46(4):431-4. PubMed ID: 17442092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.